Hydrocortisone Patent Expiration

Hydrocortisone is Used for treating adrenal insufficiency. It was first introduced by Merck And Co Inc in its drug Hydrocortone on Approved Prior to Jan 1, 1982. Other drugs containing Hydrocortisone are Hydrocortisone, Cortef, Alkindi Sprinkle, Cortril, Khindivi, Cort-Dome, Cortenema. 78 different companies have introduced drugs containing Hydrocortisone.


Hydrocortisone Patents

Given below is the list of patents protecting Hydrocortisone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Alkindi Sprinkle US9649280 Composition comprising hydrocortisone May 12, 2034 Eton
Alkindi Sprinkle US9675559 Treatment of adrenal insufficiency Jan 10, 2033 Eton
Alkindi Sprinkle US9717740 Treatment of adrenal insufficiency Nov 19, 2032 Eton



Hydrocortisone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydrocortisone Generic API Manufacturers

Several generic applications have been filed for Hydrocortisone. The first generic version for Hydrocortisone was by Bausch Health Americas Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Novitium Pharma Llc and was approved on May 2, 2025.

Given below is the list of companies who have filed for Hydrocortisone generic, along with the locations of their manufacturing plants worldwide.